Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.86) per share. This is a 79.18 percent increase over losses of $(4.13) per share from the same period last year.
Perrigo Q1 Earnings Beat Estimates On Strategic Pricing, CEO Plans Retirement
Perrigo Company plc’s (NYSE: PRGO) first-quarter FY23 sales increased nearly 10% year over year to $1.18 billion, marginally beating the consensus…